Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Etoposide | 0.1 | uM | 4 | 156.25 | 44.67 | 91.00 | 79.25 | 1.1483 | 1.3638 |
BT-20 | PLX-4720 | 0.0033113 | uM | 4 | 156.25 | 44.67 | 91.00 | 79.25 | 1.1483 | 1.3638 |
BT-20 | Nilotinib | 0.0033113 | uM | 4 | 156.25 | 44.67 | 87.00 | 79.25 | 1.0978 | 1.2388 |
BT-20 | PLX-4720 | 0.31623 | uM | 4 | 156.25 | 44.67 | 86.00 | 79.25 | 1.0852 | 1.2077 |
BT-20 | NVP-TAE684 | 0.031623 | uM | 4 | 156.25 | 44.67 | 74.00 | 79.25 | 0.9338 | 0.8410 |
BT-20 | Nilotinib | 0.31623 | uM | 4 | 156.25 | 44.67 | 77.00 | 79.25 | 0.9716 | 0.9316 |
BT-20 | NVP-TAE684 | 1 | uM | 4 | 156.25 | 44.67 | 68.00 | 79.25 | 0.8580 | 0.6621 |
BT-20 | Etoposide | 0.031623 | uM | 4 | 156.25 | 44.67 | 86.00 | 79.25 | 1.0852 | 1.2077 |
BT-20 | PLX-4720 | 1 | uM | 4 | 156.25 | 44.67 | 60.00 | 79.25 | 0.7571 | 0.4287 |
BT-20 | PLX-4720 | 0.031623 | uM | 4 | 156.25 | 44.67 | 103.00 | 79.25 | 1.2997 | 1.7457 |
BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 63.00 | 79.25 | 0.7950 | 0.5155 | |
BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 58.00 | 79.25 | 0.7319 | 0.3713 | |
BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 67.00 | 79.25 | 0.8454 | 0.6326 | |
BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 82.00 | 79.25 | 1.0347 | 1.0842 | |
BT-20 | Etoposide | 0.01 | uM | 4 | 156.25 | 44.67 | 79.00 | 79.25 | 0.9969 | 0.9924 |
BT-20 | Etoposide | 0.31623 | uM | 4 | 156.25 | 44.67 | 62.00 | 79.25 | 0.7823 | 0.4865 |
BT-20 | PLX-4720 | 0.1 | uM | 4 | 156.25 | 44.67 | 83.00 | 79.25 | 1.0473 | 1.1150 |
BT-20 | Nilotinib | 0.01 | uM | 4 | 156.25 | 44.67 | 52.00 | 79.25 | 0.6562 | 0.2017 |
BT-20 | Nilotinib | 0.1 | uM | 4 | 156.25 | 44.67 | 72.00 | 79.25 | 0.9085 | 0.7810 |
BT-20 | Etoposide | 19.9526 | uM | 4 | 156.25 | 44.67 | 47.00 | 79.25 | 0.5931 | 0.0635 |
BT-20 | PLX-4720 | 0.01 | uM | 4 | 156.25 | 44.67 | 87.00 | 79.25 | 1.0978 | 1.2388 |
BT-20 | PLX-4720 | 3.1623 | uM | 4 | 156.25 | 44.67 | 120.00 | 79.25 | 1.5142 | 2.3025 |
BT-20 | Nilotinib | 10 | uM | 4 | 156.25 | 44.67 | 400.00 | 79.25 | 5.0473 | 13.1562 |
BT-20 | NVP-TAE684 | 0.0016596 | uM | 4 | 156.25 | 44.67 | 117.00 | 79.25 | 1.4763 | 2.2030 |
BT-20 | Nilotinib | 1 | uM | 4 | 156.25 | 44.67 | 79.00 | 79.25 | 0.9969 | 0.9924 |